BR0308348A - Solução de ibuprofeno para cápsulas de invólucro duro - Google Patents

Solução de ibuprofeno para cápsulas de invólucro duro

Info

Publication number
BR0308348A
BR0308348A BR0308348-9A BR0308348A BR0308348A BR 0308348 A BR0308348 A BR 0308348A BR 0308348 A BR0308348 A BR 0308348A BR 0308348 A BR0308348 A BR 0308348A
Authority
BR
Brazil
Prior art keywords
hard shell
shell capsules
hard
ibuprofen solution
capsules
Prior art date
Application number
BR0308348-9A
Other languages
English (en)
Inventor
Emmanuelle Mireille Guillard
Nicolas Madit
Robert Anthony Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0308348A publication Critical patent/BR0308348A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"SOLUçãO DE IBUPROFENO PARA CáPSULAS DE INVóLUCRO DURO". A presente invenção refere-se a composições farmaceuticamente aceitáveis e estáveis, para cápsulas de invólucro duro de enchimento líquido, a cápsulas de invólucro duro contendo estas composições, e a um processo para a preparação destas cápsulas de invólucro duro e onde os invólucros das referidas cápsulas duras são preferivelmente transparentes límpidas.
BR0308348-9A 2002-03-11 2003-02-28 Solução de ibuprofeno para cápsulas de invólucro duro BR0308348A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290595A EP1344523A1 (en) 2002-03-11 2002-03-11 Ibuprofen solution for hard gelatin capsules
PCT/IB2003/000796 WO2003075909A1 (en) 2002-03-11 2003-02-28 Ibuprofen solution for hard shell capsules

Publications (1)

Publication Number Publication Date
BR0308348A true BR0308348A (pt) 2005-01-25

Family

ID=27763452

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308348-9A BR0308348A (pt) 2002-03-11 2003-02-28 Solução de ibuprofeno para cápsulas de invólucro duro

Country Status (15)

Country Link
US (1) US7229639B2 (pt)
EP (2) EP1344523A1 (pt)
JP (2) JP4818587B2 (pt)
KR (1) KR100679582B1 (pt)
CN (1) CN1642537A (pt)
AT (1) ATE466575T1 (pt)
AU (1) AU2003215775A1 (pt)
BR (1) BR0308348A (pt)
CA (1) CA2477393A1 (pt)
DE (1) DE60332432D1 (pt)
EA (1) EA200401067A1 (pt)
ES (1) ES2342825T3 (pt)
MX (1) MXPA04008151A (pt)
NZ (1) NZ534928A (pt)
WO (1) WO2003075909A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344523A1 (en) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofen solution for hard gelatin capsules
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
US20070071808A1 (en) * 2003-08-28 2007-03-29 Janik John J Capsule filled with honey
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
JP2007517884A (ja) * 2004-01-09 2007-07-05 ワイス 医薬組成物用のマイクロエマルジョン
CA2656540A1 (en) * 2006-06-30 2008-01-10 Mcneil-Ppc, Inc. Ibuprofen-containing liquid filled hard capsules
KR101236528B1 (ko) * 2010-06-07 2013-02-22 한국콜마주식회사 덱시부프로펜 액상 조성물을 함유하는 밀봉된 경질캡슐제
KR101346750B1 (ko) * 2010-06-07 2013-12-31 한국콜마주식회사 나프록센 액상 조성물을 함유하는 밀봉된 경질캡슐제
US9044394B2 (en) * 2010-10-18 2015-06-02 PruGen IP Holdings, Inc. Bioavailability enhancement delivery composition
EP2776016B1 (en) 2011-11-09 2019-02-20 Capsugel Belgium NV Acid resistant banding solution for acid resistant two piece hard capsules
EP3167880B1 (en) 2015-11-10 2019-06-19 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
EP3485911A4 (en) * 2016-07-06 2020-02-19 Qualicaps Co., Ltd. HARD CAPSULE WITH IMPROVED HARDNESS AND MANUFACTURING METHOD THEREOF
WO2020074361A1 (en) 2018-10-08 2020-04-16 Chanelle Pharmaceuticals Manufacturing Ltd. A soft-gel capsule formulation, method of manufacture and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5831108A (en) * 1995-08-03 1998-11-03 California Institute Of Technology High metathesis activity ruthenium and osmium metal carbene complexes
GB9605948D0 (en) * 1996-03-21 1996-05-22 Smithkline Beecham Plc Novel formulations
DE69828496T2 (de) * 1997-03-12 2006-03-23 Abbott Laboratories, Abbott Park Hydrophile binäre systeme zur verabreichung von cyclosporin
US6221391B1 (en) * 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
EP1344523A1 (en) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofen solution for hard gelatin capsules

Also Published As

Publication number Publication date
ATE466575T1 (de) 2010-05-15
CA2477393A1 (en) 2003-09-18
NZ534928A (en) 2006-09-29
CN1642537A (zh) 2005-07-20
EP1344523A1 (en) 2003-09-17
JP4818587B2 (ja) 2011-11-16
KR100679582B1 (ko) 2007-02-07
US20030211145A1 (en) 2003-11-13
KR20040101300A (ko) 2004-12-02
AU2003215775A1 (en) 2003-09-22
DE60332432D1 (de) 2010-06-17
JP2009197015A (ja) 2009-09-03
EP1485081B1 (en) 2010-05-05
EP1485081A1 (en) 2004-12-15
WO2003075909A1 (en) 2003-09-18
EA200401067A1 (ru) 2004-12-30
ES2342825T3 (es) 2010-07-15
US7229639B2 (en) 2007-06-12
MXPA04008151A (es) 2004-11-26
JP2005526758A (ja) 2005-09-08

Similar Documents

Publication Publication Date Title
BR0308348A (pt) Solução de ibuprofeno para cápsulas de invólucro duro
ATE429210T1 (de) Orale flüssige zusammensetzungen
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
KR880701544A (ko) 이온화 가능한 의약 제제용 용해 시스템
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
HUP0401224A2 (hu) Eljárás gyógyászati készítmények előállítására lágyzselatin-összetételekkel való felhasználás céljára
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
PT96330A (pt) Processo de preparacao de preparados contendo l-tartarato de l-carnitina
ES2171268T3 (es) Formulaciones de tramadol de multiples unidades.
NO20014102L (no) Nye tricykliske forbindelser og deres anvendelse innenfor medisin, fremgangsmåte for deres fremstilling og farmasöytisksammensetning som inneholder dem
BR0313555A (pt) Aplicação de inibidores de ikb-cinase na terapia da dor
BR9912240A (pt) Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos
ME00454B (me) Nova so perindoprila i farmaceutske kompozicije koje sadrže tu so
NO20052216L (no) Smertestillende midler
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
BR0209856A (pt) Método para a destruição de oocistos
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
EA200100226A1 (ru) Топикальные, содержащие нимесулид фармацевтические составы
DK1513500T3 (da) Farmaceutiske præparater til oral indgivelse indeholdende pradofloxacin-chargerede ionbytterharpikser samt strukturvisköse geldannere som fortykkelsesmidler
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
BRPI0408403A (pt) pó cristalino de triidrato de amoxicilina
AU2003269266A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/192, 47/02, 47/14, 47/34, 47/44, 9/48; A61P 25/04, 29/00

Ipc: A61K 31/192 (2011.01), A61K 47/02 (2011.01), A61K

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A, 8A E 9A ANUIDADES.